Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID06359444

Effect of High Intensity Exercise Rehabilitation on Liver Function, Insulin Sensitivity, and Cardiovascular Risk in Patients With MASLD

Led by University Ghent · Updated on 2024-06-07

92

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University Ghent

Lead Sponsor

U

University Hospital, Ghent

Collaborating Sponsor

AI-Summary

What this Trial Is About

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease worldwide and is linked to obesity and metabolic syndrome. This trial compares two types of combined exercise training programs to study their effects on liver fat severity and related health factors. The research aims to explore how strength and aerobic training versus strength and high-intensity interval training (HIIT) impact liver health and insulin sensitivity in MASLD patients. Participants are randomly assigned to one of two groups. One group exercises with a combination of strength and aerobic training for 14 weeks, including twice-weekly sessions at the rehabilitation center and one at home. The other group starts with 6 weeks of combined strength and aerobic training, then switches to 8 weeks of combined strength and HIIT, following the same session schedule. Each session lasts about one hour. Throughout the 14-week program, participants undergo assessments before and after training to measure liver fat by ultrasound and CAP, insulin sensitivity, liver enzymes, exercise capacity, strength, cardiovascular function, body measurements, inflammation markers, and quality of life. Researchers monitor progress and health changes with these tests to evaluate the effects of the exercise interventions on MASLD. The study is conducted at the university hospital and rehabilitation center in Ghent.

CONDITIONS

Brief Title

Effect of High Intensity Exercise Rehabilitation on Liver Function and Insulin Sensitivity in Patients With MASLD

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with MASLD by ultrasound, CAP, and/or biopsy
  • Aged between 18 and 75 years old
  • No significant liver fibrosis (Fibroscan less than 7.5 kPa; if between 7.5 and 10, biopsy must show no liver fibrosis)
Not Eligible

You will not qualify if you...

  • Presence of other liver diseases that affect the patient's condition
  • Severe cardiovascular, orthopedic, physical, or other illnesses preventing safe participation in exercise rehabilitation
  • Pregnancy
  • Use of medications that directly affect MASLD, such as GLP-1 analogues
  • Change in medication affecting metabolic disease stability within the last three months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 14 weeks

Participants follow a 14-week exercise rehabilitation program involving combined strength and aerobic or strength and high intensity interval training (HIIT). Sessions occur three times per week, with two sessions at the rehabilitation center and one session at home, each lasting about one hour.

Three sessions per week (2 in-person, 1 at home)

Trial Site Locations

Total: 1 location

1

Ghent University Hospital

Ghent, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

P

Patrick Calders, Prof. dr.

S

Sander Lefere, dr.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Large Language Model-based Chatbot for Alcohol Reduction C...

Metabolic Dysfunction-Associated Steatotic Liver Disease

Actively Recruiting

1 location

A Master Protocol for a Randomized, Controlled Trial of Reta...

Metabolic Dysfunction-Associated Steatotic Liver Disease

Actively Recruiting

561 locations

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Stud...

Metabolic Dysfunction-Associated Steatotic Liver Disease

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.

Thomas Karlas, David Petroff, Magali Sasso...

https://pubmed.ncbi.nlm.nih.gov/28039099